NSD3 and head and neck squamous cell carcinoma: Similarly, the percentage of samples with strong (+3) expression of WHSC1L1 increased significantly from 0% to 6% from normal to dyplastic epithelium, and then to 25% in SCCHN (P=0.0032, Cochrane-Armitage test) (Figure 1B).